STMN1 and cancer: High STMN1 levels have been detected in various malignancies, and they are associated with accelerated tumor progression.[21, 23, 41, 42] In addition, STMN1 is an important response factor to clinical chemotherapy in patients with paclitaxel‐resistant tumors and is closely associated with chemoresistance of tumors.[22, 23] However, to our knowledge, the expression level and the role of such an important cancer‐related protein in intrahepatic cholangiocarcinoma have not been reported so far.